Cite
HARVARD Citation
Zou, Z. et al. (2014). 3-Methyladenine can depress drug efflux transporters via blocking the PI3K–AKT–mTOR pathway thus sensitizing MDR cancer to chemotherapy. Journal of drug targeting. pp. 839-848. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zou, Z. et al. (2014). 3-Methyladenine can depress drug efflux transporters via blocking the PI3K–AKT–mTOR pathway thus sensitizing MDR cancer to chemotherapy. Journal of drug targeting. pp. 839-848. [Online].